RxGenomix's training program in Pharmacogenomics has been approved by the American Pharmacists Association as a continuing pharmacy education credit. Read More »

Rite Aid's Black Friday deals continue through the weekend. Read More »

According a new research study conducted by Visante, pharmacy benefit managers are saving consumers and payers $941 on average per person a year. Read More »

Centers for Disease Control and Prevention President and CEO Dr. Judith Monroe has received the 2016 NACDS Foundation Excellence in Patient Care Award. Read More »

A new report by the Surgeon General has discovered that alcohol and drug misuse and severe substance addiction is one of the nation’s crucial health concerns. Read More »

The American Pharmacists Association recently released a video that commemorates its Pharmacy-based Immunization Certificate Training Program’s 20th anniversary. Read More »

Cigna is asking medical groups to join the effort of decreasing opioid use by 25 percent by signing a pledge to reduce opioid prescriptions and treat opioid abuse as a chronic condition. Read More »

Amgen will partner with Janssen Biotech to assess the drug combination made up of KYPROLIS, developed by Amgen, and DARZALEX, developed by Janssen, over the course of multiple clinical trials for the treatment of patients who have multiple myeloma. Read More »

Naloxone has been made available without the need for a prescription in all Walgreens pharmacy locations in the Louisiana. Read More »

The American Society of Health System Pharmacists is accepting applications for its 2017 ASHP Executive Residency in Association Leadership and Management. Read More »

The American Journal of Health-System Pharmacy has launched its redesigned website, AJHP.org. Read More »

To kick off the holiday season, Cigna has released “Holiday Survival Tips.” Read More »

Omnicell has finalized an agreement for the acquisition of Ateb Inc. and its affiliate, Ateb Canada Ltd. Read More »

The U.S. Food and Drug Administration has approved Armodafinil Tablets developed by Lupin Pharmaceuticals. Read More »

Biological Industries' Drug Master File for NutriStem hPSC XF Medium has been accepted by the U.S. Food and Drug Administration. Read More »

Otsuka Pharmaceuticals and Lundbeck's supplemental New Drug Application for the expanded labeling of ABILIFY MAINENA has been completed and will receive a substantive review by the U.S. Food and Drug Administration. Read More »

Upsher-Smith Laboratories Inc. will have three poster presentations at the American Epilepsy Society’s 70th annual meeting, running through Tuesday in Houston. Read More »

Cigna will be implementing an integrated hi-tech/hi-touch approach when it comes to the support and service of its customers. Read More »

AbbVie's risankizumab has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for the investigational treatment of pediatric patients who have Crohn’s disease. Read More »

Eisai Inc. has released the final results of its Phase 3 rufinamide study, an open-label, two-year investigation. Read More »